GRI Bio Stock (NASDAQ: GRI) stock price, news, charts, stock research, profile.
Open | $0.452 |
Close | $0.420 |
Volume / Avg. | 254.519K / 294.383K |
Day Range | 0.413 - 0.452 |
52 Wk Range | 0.375 - 49.280 |
Market Cap | $1.435M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 0.44% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GRI Bio (NASDAQ: GRI) through any online brokerage.
Other companies in GRI Bio’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX), Qualigen Therapeutics (NASDAQ:QLGN) and Finch Therapeutics Gr (NASDAQ:FNCH).
There is no analysis for GRI Bio.
The stock price for GRI Bio (NASDAQ: GRI) is $0.449 last updated May 17, 2024 at 9:12 AM EDT.
A quarterly cash dividend of $0.51 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2019 to stockholders of record on December 19, 2019.
GRI Bio’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for GRI Bio.
GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.